Informazione:
Errore:
ID
22001
Descrizione
Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01201343
collegamento
https://clinicaltrials.gov/show/NCT01201343
Keywords
versioni (1)
- 14/05/17 14/05/17 -
Caricato su
14 maggio 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Multiple Sclerosis, Relapsing, Remitting NCT01201343
Eligibility Multiple Sclerosis, Relapsing, Remitting NCT01201343
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis, Relapsing, Remitting NCT01201343
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Age
Item
male and female subjects aged ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
subjects with rrms
boolean
C0751967 (UMLS CUI [1])
Relapse Quantity | Relapse Last Ended
Item
subjects with at least 2 relapses in the past two years (with last relapse finished or finishing)
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0035020 (UMLS CUI [2,1])
C1517741 (UMLS CUI [2,2])
C1272693 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C0035020 (UMLS CUI [2,1])
C1517741 (UMLS CUI [2,2])
C1272693 (UMLS CUI [2,3])
Indication Beta interferon therapy
Item
subjects with indication of ifn beta treatment determined by the investigator
boolean
C3146298 (UMLS CUI [1,1])
C0854622 (UMLS CUI [1,2])
C0854622 (UMLS CUI [1,2])
Inclusion criteria Study Protocol
Item
other protocol-defined inclusion criteria may apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Multiple Sclerosis, Secondary Progressive | Recurrent disease Absent
Item
subjects with secondary progressive multiple sclerosis (ms) without relapse
boolean
C0751965 (UMLS CUI [1])
C0277556 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Recurrent disease
Item
subjects with ongoing acute relapse
boolean
C0277556 (UMLS CUI [1])
Interferon
Item
subjects already being treated with interferon
boolean
C3652465 (UMLS CUI [1])
Adrenal Cortex Hormones
Item
subjects with corticoid therapy for less than 15 days
boolean
C0001617 (UMLS CUI [1])
Major Depressive Disorder | Antidepressive Agents
Item
subjects presenting acute major depression or treated with anti-depressant therapy
boolean
C1269683 (UMLS CUI [1])
C0003289 (UMLS CUI [2])
C0003289 (UMLS CUI [2])
Study Subject Participation Status
Item
subjects involved in another therapeutic study
boolean
C2348568 (UMLS CUI [1])
Condition Interferes with Protocol Compliance
Item
subjects with any condition which could interfere with a good compliance of this study
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])